PT - JOURNAL ARTICLE AU - Bahri, Muhamad Khairul TI - Modeling the flow of the COVID-19 in Germany: The efficacy of lockdowns and social behavior AID - 10.1101/2020.12.21.20248605 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.21.20248605 4099 - http://medrxiv.org/content/early/2020/12/28/2020.12.21.20248605.short 4100 - http://medrxiv.org/content/early/2020/12/28/2020.12.21.20248605.full AB - This study develops a computer simulation in understanding the flow of the COVID-19 in Germany between January 2020 and July 2020. This aims to analyze not only the flow of the COVID-19 but also the efficacy of taken measures during the given period. The computer model is based on the SEIR concept and it is based on the system dynamics approach in which some uncertain parameters are estimated through the calibration process. Moreover, the SEIR computer model is developed by considering different flows of COVID-19 cases in older and young people in Germany. This study successfully reproduces similar patterns of infected, recovered, and death cases. Moreover, as the SEIR model can successfully reproduce similar patterns, the SEIR model can be a basis to estimate other resources such as health workers, and bed capacities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThere is no given fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no ethical neededAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesdata is available in model dataset:germany_model_ref.vdf